(WIX) Wix.Com - Overview
Stock: Website Builder, App Development, E-commerce, Marketing Tools, Business
| Risk 5d forecast | |
|---|---|
| Volatility | 65.8% |
| Relative Tail Risk | -17.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.02 |
| Alpha | -72.58 |
| Character TTM | |
|---|---|
| Beta | 1.124 |
| Beta Downside | 1.013 |
| Drawdowns 3y | |
|---|---|
| Max DD | 74.55% |
| CAGR/Max DD | 0.03 |
EPS (Earnings per Share)
Revenue
Description: WIX Wix.Com March 05, 2026
Wix.com Ltd. operates a cloud-based web development platform. Its core offering includes drag-and-drop website builders like Wix Editor and Wix Studio, catering to a wide range of users from individuals to businesses. The companys business model is primarily subscription-based, offering various tiers of service and additional features.
Wix provides a comprehensive ecosystem of tools and services. These include Velo by Wix for advanced development, the Wix App Market for third-party integrations, and Wix Marketplace connecting users with web development professionals. The company also offers mobile applications for site management and customer interaction.
Beyond website creation, Wix integrates commerce solutions. This includes Payments by Wix, Wix POS for omnichannel sales, and tools for managing stores and bookings. The company also provides marketing services, domain registration, and AI-powered logo generation. This diversified offering within the Internet Services & Infrastructure sector aims to provide a complete digital presence solution.
For a deeper dive into WIXs financial performance and competitive landscape, ValueRay offers detailed analysis.
Headlines to watch out for
- Subscription growth for website building and business tools drives revenue
- Competition from rival website builders impacts market share
- Small business spending on online presence dictates demand
- Global economic downturn reduces new website creation
- Data privacy regulations could increase compliance costs
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 138.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.22 > 0.02 and ΔFCF/TA -2.54 > 1.0 |
| NWC/Revenue: 34.86% < 20% (prev -21.77%; Δ 56.63% < -1%) |
| CFO/TA 0.23 > 3% & CFO 576.2m > Net Income 138.9m |
| Net Debt (671.9m) to EBITDA (195.6m): 3.44 < 3 |
| Current Ratio: 1.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.7m) vs 12m ago -4.33% < -2% |
| Gross Margin: 68.45% > 18% (prev 0.68%; Δ 6777 % > 0.5%) |
| Asset Turnover: 90.30% > 50% (prev 99.39%; Δ -9.09% > 0%) |
| Interest Coverage Ratio: 4.31 > 6 (EBITDA TTM 195.6m / Interest Expense TTM 38.4m) |
Altman Z'' 0.92
| A: 0.26 (Total Current Assets 1.75b - Total Current Liabilities 1.08b) / Total Assets 2.56b |
| B: -0.32 (Retained Earnings -810.7m / Total Assets 2.56b) |
| C: 0.08 (EBIT TTM 165.3m / Avg Total Assets 2.14b) |
| D: -0.28 (Book Value of Equity -786.9m / Total Liabilities 2.84b) |
| Altman-Z'' Score: 0.92 = BB |
Beneish M -2.67
| DSRI: 0.96 (Receivables 54.7m/50.2m, Revenue 1.93b/1.70b) |
| GMI: 0.99 (GM 68.45% / 67.89%) |
| AQI: 1.80 (AQ_t 0.11 / AQ_t-1 0.06) |
| SGI: 1.13 (Revenue 1.93b / 1.70b) |
| TATA: -0.17 (NI 138.9m - CFO 576.2m) / TA 2.56b) |
| Beneish M-Score: -2.67 (Cap -4..+1) = A |
What is the price of WIX shares?
Over the past week, the price has changed by +26.79%, over one month by +20.67%, over three months by -12.95% and over the past year by -46.01%.
Is WIX a buy, sell or hold?
- StrongBuy: 13
- Buy: 7
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WIX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 146.7 | 59.5% |
| Analysts Target Price | 146.7 | 59.5% |
WIX Fundamental Data Overview March 06, 2026
P/E Forward = 10.4932
P/S = 2.4183
P/B = 39.1296
P/EG = 0.4354
Revenue TTM = 1.93b USD
EBIT TTM = 165.3m USD
EBITDA TTM = 195.6m USD
Long Term Debt = 1.12b USD (from longTermDebt, last quarter)
Short Term Debt = 42.4m USD (from shortTermDebt, last quarter)
Debt = 1.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 671.9m USD (from netDebt column, last quarter)
Enterprise Value = 4.64b USD (4.67b + Debt 1.57b - CCE 1.59b)
Interest Coverage Ratio = 4.31 (Ebit TTM 165.3m / Interest Expense TTM 38.4m)
EV/FCF = 8.19x (Enterprise Value 4.64b / FCF TTM 567.1m)
FCF Yield = 12.22% (FCF TTM 567.1m / Enterprise Value 4.64b)
FCF Margin = 29.40% (FCF TTM 567.1m / Revenue TTM 1.93b)
Net Margin = 7.20% (Net Income TTM 138.9m / Revenue TTM 1.93b)
Gross Margin = 68.45% ((Revenue TTM 1.93b - Cost of Revenue TTM 608.7m) / Revenue TTM)
Gross Margin QoQ = 68.34% (prev 68.70%)
Tobins Q-Ratio = 1.81 (Enterprise Value 4.64b / Total Assets 2.56b)
Interest Expense / Debt = 2.44% (Interest Expense 38.4m / Debt 1.57b)
Taxrate = 8.95% (13.6m / 151.9m)
NOPAT = 150.5m (EBIT 165.3m * (1 - 8.95%))
Current Ratio = 1.62 (Total Current Assets 1.75b / Total Current Liabilities 1.08b)
Debt / Equity = -5.64 (negative equity) (Debt 1.57b / totalStockholderEquity, last quarter -278.8m)
Debt / EBITDA = 3.44 (Net Debt 671.9m / EBITDA 195.6m)
Debt / FCF = 1.18 (Net Debt 671.9m / FCF TTM 567.1m)
Total Stockholder Equity = -161.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.50% (Net Income 138.9m / Total Assets 2.56b)
RoE = -86.30% (negative equity) (Net Income TTM 138.9m / Total Stockholder Equity -161.0m)
RoCE = 17.16% (EBIT 165.3m / Capital Employed (Equity -161.0m + L.T.Debt 1.12b))
RoIC = 27.34% (NOPAT 150.5m / Invested Capital 550.4m)
WACC = 8.09% (E(4.67b)/V(6.24b) * Re(10.06%) + D(1.57b)/V(6.24b) * Rd(2.44%) * (1-Tc(0.09)))
Discount Rate = 10.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.95%
[DCF] Terminal Value 80.98% ; FCFF base≈509.7m ; Y1≈628.7m ; Y5≈1.07b
[DCF] Fair Price = 311.9 (EV 17.78b - Net Debt 671.9m = Equity 17.11b / Shares 54.9m; r=8.09% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 86.75 | EPS CAGR: 124.8% | SUE: 2.09 | # QB: 3
Revenue Correlation: 98.92 | Revenue CAGR: 12.18% | SUE: 1.18 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.47 | Chg7d=-0.200 | Chg30d=-0.200 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=6.44 | Chg7d=-0.241 | Chg30d=-0.241 | Revisions Net=-2 | Growth EPS=-12.0% | Growth Revenue=+15.1%
EPS next Year (2027-12-31): EPS=7.84 | Chg7d=+0.065 | Chg30d=+0.065 | Revisions Net=+0 | Growth EPS=+21.7% | Growth Revenue=+12.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.2% (Discount Rate 10.1% - Earnings Yield 2.8%)
[Growth] Growth Spread = +7.9% (Analyst 15.1% - Implied 7.2%)